Lucid Diagnostics Inc. SEC filings LUCD

Lucid Diagnostics Inc. has 281 filings in SEC EDGAR's recent list, going back to Jan 21, 2020. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (unregistered share sale, change to shareholder rights, bylaw or fiscal year change). The company's fiscal year ends on December 31.

Lucid Diagnostics Inc. SEC filings
Form Description Filed Period
4 Insider transaction May 21, 2026 May 20, 2026
3/A Amended initial statement of beneficial ownership of securities Apr 24, 2026 Mar 23, 2026
3 Initial insider ownership Apr 13, 2026 Mar 23, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Feb 9, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Oct 10, 2025 —
4 Insider transaction Oct 7, 2025 Oct 6, 2025
3 Initial insider ownership Oct 7, 2025 Sep 22, 2025
4 Insider transaction Aug 22, 2025 Aug 20, 2025
4/A Amended statement of changes in beneficial ownership of securities May 23, 2025 May 20, 2025
4 Insider transaction May 22, 2025 May 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
4 Insider transaction Feb 21, 2025 Feb 20, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SC 13D/A Amended ownership over 5% (active) Dec 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jul 8, 2024 —
4 Insider transaction May 9, 2024 May 8, 2024
3 Initial insider ownership May 9, 2024 May 6, 2024
4 Insider transaction May 8, 2024 May 7, 2024
4 Insider transaction May 8, 2024 May 7, 2024
4 Insider transaction May 8, 2024 May 7, 2024
4 Insider transaction May 8, 2024 May 7, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 23, 2024 Feb 22, 2024
4 Insider transaction Feb 20, 2024 Feb 15, 2024
SC 13D/A Amended ownership over 5% (active) Feb 20, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13D/A Amended ownership over 5% (active) Feb 2, 2024 —
4 Insider transaction Jan 30, 2024 Jan 26, 2024
4 Insider transaction Sep 27, 2023 Sep 25, 2023
4/A Amended statement of changes in beneficial ownership of securities Sep 27, 2023 Sep 20, 2023
144 Notice of proposed sale Sep 26, 2023 —
4 Insider transaction Sep 22, 2023 Sep 20, 2023
4/A Amended statement of changes in beneficial ownership of securities Apr 13, 2023 Nov 30, 2022
3 Initial insider ownership Apr 6, 2023 Mar 18, 2022
SC 13G/A Amended ownership over 5% (passive) Mar 24, 2023 —
SC 13G Ownership over 5% (passive) Mar 23, 2023 —
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Feb 2, 2023 Jan 31, 2023
4 Insider transaction Dec 2, 2022 Nov 30, 2022
SC 13D/A Amended ownership over 5% (active) Dec 2, 2022 —
4 Insider transaction Sep 22, 2022 Sep 20, 2022
4 Insider transaction Aug 2, 2022 Aug 2, 2022
3 Initial insider ownership Aug 2, 2022 Aug 1, 2022
4 Insider transaction Jun 9, 2022 Jun 7, 2022
3 Initial insider ownership Jun 8, 2022 May 31, 2022
4 Insider transaction Feb 24, 2022 Feb 18, 2022
4 Insider transaction Feb 23, 2022 Feb 18, 2022
4 Insider transaction Feb 23, 2022 Feb 18, 2022
4 Insider transaction Feb 23, 2022 Feb 18, 2022
4 Insider transaction Feb 23, 2022 Feb 18, 2022
4 Insider transaction Feb 23, 2022 Feb 18, 2022
4 Insider transaction Feb 23, 2022 Feb 18, 2022
4 Insider transaction Jan 10, 2022 Jan 7, 2022
4 Insider transaction Jan 10, 2022 Jan 7, 2022
SC 13D Ownership over 5% (active) Oct 27, 2021 —
4 Insider transaction Oct 20, 2021 Oct 18, 2021
4 Insider transaction Oct 20, 2021 Oct 18, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021
3 Initial insider ownership Oct 13, 2021 Oct 13, 2021

Showing 91 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
LUCD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
, Emerging growth company
SEC CIK
1799011

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.